z-logo
Premium
Bumetanide‐sensitive Na+ /K+ /Cl− transporter is stimulated by phorbol ester and different mitogens in quiescent human skin fibroblasts
Author(s) -
Panet Rivka,
Atlan Henri
Publication year - 1990
Publication title -
journal of cellular physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.529
H-Index - 174
eISSN - 1097-4652
pISSN - 0021-9541
DOI - 10.1002/jcp.1041450106
Subject(s) - protein kinase c , bumetanide , growth factor , phorbol , fibroblast growth factor , chemistry , platelet derived growth factor receptor , platelet derived growth factor , fibroblast , epidermal growth factor , endocrinology , medicine , protein kinase a , microbiology and biotechnology , signal transduction , biology , biochemistry , kinase , receptor , in vitro , ion transporter , membrane
In this study we investigated the correlation between the mitogenic effect and stimulation of Rb + (K + ) fluxes in human skin fibroblasts treated by purified growth factors. Both K+ transporters, bumetanide‐sensitive and ouabain‐sensitive, are stimulated 2‐3‐fold after addition of either fetal calf serum or purified recombinant growth factors to quiescent G 0 /G 1 human skin fibroblasts. Three groups of mitogens were compared: (i) the phorbol ester 2‐O‐tetradecanoyl‐phorbol‐13‐acetate (TPA); (ii) growth factors that stimulate inositol phosphate hydrolysis and subsequently activate protein kinase C—fibroblast growth factor (FGF), platelet derived growth factor (PDGF), and α‐thrombin; and (iii) growth factors that do not activate kinase C—insulin‐like growth factor‐1 (IGF‐1), and transforming like growth‐factor‐α (TGF‐α). The three groups of mitogens stimulated human skin fibroblasts proliferation and Rb+ influxes in a similar dose‐dependent fashion. The results indicate that both the bumetanide‐sensitive and the ouabain‐sensitive Rb+ fluxes are stimulated by protein kinase C‐dependent and by the protein kinase C‐independent pathways of the mitogenic signal.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here